326 related articles for article (PubMed ID: 28852307)
21. [Standards, perspectives and limits of conservative therapy of chronic inflammatory bowel diseases].
Rogler G; Andus T; Schölmerich J
Zentralbl Chir; 1998; 123(4):316-24. PubMed ID: 9622888
[TBL] [Abstract][Full Text] [Related]
22. The Role of Diet in the Pathogenesis and Management of Inflammatory Bowel Disease: A Review.
Wark G; Samocha-Bonet D; Ghaly S; Danta M
Nutrients; 2020 Dec; 13(1):. PubMed ID: 33396537
[TBL] [Abstract][Full Text] [Related]
23. Donor Species Richness Determines Faecal Microbiota Transplantation Success in Inflammatory Bowel Disease.
Vermeire S; Joossens M; Verbeke K; Wang J; Machiels K; Sabino J; Ferrante M; Van Assche G; Rutgeerts P; Raes J
J Crohns Colitis; 2016 Apr; 10(4):387-94. PubMed ID: 26519463
[TBL] [Abstract][Full Text] [Related]
24. [Inflammatory bowel diseases (IBD) -- critical discussion of etiology, pathogenesis, diagnostics, and therapy].
Ochsenkühn T; Sackmann M; Göke B
Radiologe; 2003 Jan; 43(1):1-8. PubMed ID: 12552369
[TBL] [Abstract][Full Text] [Related]
25. Inflammatory bowel disease: A descriptive study of 716 local Chilean patients.
Simian D; Fluxá D; Flores L; Lubascher J; Ibáñez P; Figueroa C; Kronberg U; Acuña R; Moreno M; Quera R
World J Gastroenterol; 2016 Jun; 22(22):5267-75. PubMed ID: 27298570
[TBL] [Abstract][Full Text] [Related]
26. Emerging biologics in inflammatory bowel disease.
Chan HC; Ng SC
J Gastroenterol; 2017 Feb; 52(2):141-150. PubMed ID: 27832357
[TBL] [Abstract][Full Text] [Related]
27. Incidence rates and disease course of paediatric inflammatory bowel diseases in Western Hungary between 1977 and 2011.
Lovasz BD; Lakatos L; Horvath A; Pandur T; Erdelyi Z; Balogh M; Szipocs I; Vegh Z; Veres G; Müller KE; Golovics PA; Kiss LS; Mandel MD; Lakatos PL
Dig Liver Dis; 2014 May; 46(5):405-11. PubMed ID: 24495511
[TBL] [Abstract][Full Text] [Related]
28. Insights on the use of biosimilars in the treatment of inflammatory bowel disease.
Zheng MK; Shih DQ; Chen GC
World J Gastroenterol; 2017 Mar; 23(11):1932-1943. PubMed ID: 28373759
[TBL] [Abstract][Full Text] [Related]
29. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
Nørgård BM
Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
[TBL] [Abstract][Full Text] [Related]
30. New and emerging biologics in the treatment of inflammatory bowel disease: quo vadis?
Danese S; Angelucci E
Gastroenterol Clin Biol; 2009 Jun; 33 Suppl 3():S217-27. PubMed ID: 20117345
[TBL] [Abstract][Full Text] [Related]
31. How will insights from genetics translate to clinical practice in inflammatory bowel disease?
Festen EA; Weersma RK
Best Pract Res Clin Gastroenterol; 2014 Jun; 28(3):387-97. PubMed ID: 24913379
[TBL] [Abstract][Full Text] [Related]
32. ECCO position statement: the use of biosimilar medicines in the treatment of inflammatory bowel disease (IBD).
Danese S; Gomollon F;
J Crohns Colitis; 2013 Aug; 7(7):586-9. PubMed ID: 23623738
[TBL] [Abstract][Full Text] [Related]
33. Intestinal microbiota, fecal microbiota transplantation, and inflammatory bowel disease.
Weingarden AR; Vaughn BP
Gut Microbes; 2017 May; 8(3):238-252. PubMed ID: 28609251
[TBL] [Abstract][Full Text] [Related]
34. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.
Magro F; Portela F
BioDrugs; 2010 Dec; 24 Suppl 1():3-14. PubMed ID: 21175228
[TBL] [Abstract][Full Text] [Related]
35. Protocol for a double-blind, randomised, placebo-controlled pilot study for assessing the feasibility and efficacy of faecal microbiota transplant in a paediatric Crohn's disease population: PediCRaFT Trial.
Pai N; Popov J; Hill L; Hartung E
BMJ Open; 2019 Nov; 9(11):e030120. PubMed ID: 31784432
[TBL] [Abstract][Full Text] [Related]
36. STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD.
Turner D; Ricciuto A; Lewis A; D'Amico F; Dhaliwal J; Griffiths AM; Bettenworth D; Sandborn WJ; Sands BE; Reinisch W; Schölmerich J; Bemelman W; Danese S; Mary JY; Rubin D; Colombel JF; Peyrin-Biroulet L; Dotan I; Abreu MT; Dignass A;
Gastroenterology; 2021 Apr; 160(5):1570-1583. PubMed ID: 33359090
[TBL] [Abstract][Full Text] [Related]
37. [Treatment of inflammatory bowel disease].
Schölmerich J
Praxis (Bern 1994); 2007 Feb; 96(9):337-43. PubMed ID: 17361635
[TBL] [Abstract][Full Text] [Related]
38. Incidence and Treatment of Patients Diagnosed With Inflammatory Bowel Diseases at 60 Years or Older in Sweden.
Everhov ÅH; Halfvarson J; Myrelid P; Sachs MC; Nordenvall C; Söderling J; Ekbom A; Neovius M; Ludvigsson JF; Askling J; Olén O
Gastroenterology; 2018 Feb; 154(3):518-528.e15. PubMed ID: 29102619
[TBL] [Abstract][Full Text] [Related]
39. Thiopurines and inflammatory bowel disease: Current evidence and a historical perspective.
Axelrad JE; Roy A; Lawlor G; Korelitz B; Lichtiger S
World J Gastroenterol; 2016 Dec; 22(46):10103-10117. PubMed ID: 28028358
[TBL] [Abstract][Full Text] [Related]
40. The risk for opportunistic infections in inflammatory bowel disease with biologics: an update.
Borman ZA; Côté-Daigneault J; Colombel JF
Expert Rev Gastroenterol Hepatol; 2018 Nov; 12(11):1101-1108. PubMed ID: 30277409
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
